| I Advice |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Supplements > Theories upon the Role of Colloidal Silver |
|
I Advice - Theories upon the Role of Colloidal Silver
Colloidal silver – an antibiotic, a supplement, an effective medicine with a long history. Colloidal silver h According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product as proved to be all the above and, furthermore, it is gaining more users and more specialists that promote th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e positive effects of colloidal silver. But how does it actually work? How does it manage to kill the unwante lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. d viruses and to restore health? There are many theories regarding this aspect and the researches still conti here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ue. Some consider that the silver particles are actual catalysts, oxidizing catalysts, to be exact. These ca d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro talysts supposedly eliminate the unwanted pathogens from the human body. Other specialists claim that the col ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc loidal silver is able to reduce the sulfur concentration of the microbe, while others consider that the collo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi idal silver is able to interfere with the electrostatic balance of the pathogen cell. Still, most theories cl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically im one fact: that the colloidal silver interferes with the cell’s “lung” or, better said, with the breathing and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ system of the cell. All these pathogen cells breathe in the presence of a metabolic enzyme. Facts proved that ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi colloidal silver can actually kill this breathing enzyme and, therefore, the breathing process of the pathog ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a en cell is stopped. Just like in the case of any beings, the cells can not live without breathing. Still, wh dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod n it comes to some specific viruses, there are more theories. Some specialists say that the colloidal silver cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin is able to repair the damaged parts of a virus – still, even if this might seem like a pro-virus action, it i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s not. What actually happens is that the virus, after the competition process ends, is not a functional virus t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel anymore and, therefore, it can not function as a pathogen cell and it can not multiply. Considering the fact ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust all viruses usually multiply very fast, this fact is of great relevance. Regardless of the main reason why c y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products olloidal silver is able to destroy the viruses and other unwanted pathogens, the facts remain the same: there . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de is a long history that proves the efficiency of this supplement or medicine and there are many contemporary elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip cases that sustain the fact that colloidal silver has proven to be more effective than the conventional drugs tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:20 Something's - Perfect Time To Start A Home Based Internet Business Reasons Why Women Fall in Love with Older Men
|